Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.740
+0.080 (1.72%)
At close: Apr 14, 2026, 4:00 PM EDT
4.740
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:00 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts that cover Bolt Biotherapeutics stock have a consensus rating of "Strong Buy" and an average price target of $34, which forecasts a 617.30% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $75.
Price Target: $34 (+617.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 13, 2026.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +47.68% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +47.68% | Oct 20, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $4 → $75 | Strong Buy | Maintains | $4 → $75 | +1,482.28% | Aug 15, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +1,587.76% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $25 → $20 | Hold | Maintains | $25 → $20 | +321.94% | May 13, 2025 |
Financial Forecast
Revenue This Year
3.06M
from 7.70M
Decreased by -60.23%
Revenue Next Year
7.14M
from 3.06M
Increased by 133.33%
EPS This Year
-21.85
from -17.85
EPS Next Year
-40.39
from -21.85
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.3M | 7.4M | |||
| Avg | 3.1M | 7.1M | |||
| Low | n/a | 6.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -18.1% | 140.2% | |||
| Avg | -60.2% | 133.3% | |||
| Low | - | 124.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -10.02 | -41.58 | |||
| Avg | -21.85 | -40.39 | |||
| Low | -32.63 | -38.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.